These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9266218)

  • 21. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
    Xu J; Jakher Y; Ahrens-Nicklas RC
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Domino liver transplantation in maple syrup urine disease.
    Khanna A; Hart M; Nyhan WL; Hassanein T; Panyard-Davis J; Barshop BA
    Liver Transpl; 2006 May; 12(5):876-82. PubMed ID: 16628687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical methods to estimate whole body leucine oxidation in maple syrup urine disease.
    Elsas LJ; Ellerine NP; Klein PD
    Pediatr Res; 1993 May; 33(5):445-51. PubMed ID: 8511017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypervalinemia and hyperleucine-isoleucinemia caused by mutations in the branched-chain-amino-acid aminotransferase gene.
    Wang XL; Li CJ; Xing Y; Yang YH; Jia JP
    J Inherit Metab Dis; 2015 Sep; 38(5):855-61. PubMed ID: 25653144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
    Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
    Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein and leucine metabolism in maple syrup urine disease.
    Thompson GN; Bresson JL; Pacy PJ; Bonnefont JP; Walter JH; Leonard JV; Saudubray JM; Halliday D
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E654-60. PubMed ID: 2185648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria.
    Parsons HG; Carter RJ; Unrath M; Snyder FF
    J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease.
    Morais FA; Lemos IS; Matiola RT; Freitas MLS; Alano CG; Cabral J; Wessler LB; Generoso JS; Scaini G; Réus GZ; Streck EL
    Metab Brain Dis; 2022 Jun; 37(5):1585-1596. PubMed ID: 35394251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
    Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
    Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease.
    Scaini G; Teodorak BP; Jeremias IC; Morais MO; Mina F; Dominguini D; Pescador B; Comim CM; Schuck PF; Ferreira GC; Quevedo J; Streck EL
    Behav Brain Res; 2012 May; 231(1):92-6. PubMed ID: 22433584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular levels and metabolism of leucine and alpha-ketoisocaproate in normal and maple syrup urine disease fibroblasts.
    Wendel U; Langenbeck U
    Biochem Med; 1984 Jun; 31(3):294-302. PubMed ID: 6477534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPM1K defects cause mild maple syrup urine disease: The second case in the literature.
    Ozcelik F; Arslan S; Ozguc Caliskan B; Kardas F; Ozkul Y; Dundar M
    Am J Med Genet A; 2023 May; 191(5):1360-1365. PubMed ID: 36706222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markers associated with inborn errors of metabolism of branched-chain amino acids and their relevance to upper levels of intake in healthy people: an implication from clinical and molecular investigations on maple syrup urine disease.
    Mitsubuchi H; Owada M; Endo F
    J Nutr; 2005 Jun; 135(6 Suppl):1565S-70S. PubMed ID: 15930470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates.
    Skvorak K; Liu J; Kruse N; Mehmood R; Das S; Jenne S; Chng C; Lao UL; Duan D; Asfaha J; Du F; Teadt L; Sero A; Ching C; Riggins J; Pope L; Yan P; Mashiana H; Ismaili MHA; McCluskie K; Huisman G; Silverman AP
    J Inherit Metab Dis; 2023 Nov; 46(6):1089-1103. PubMed ID: 37494004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clues and challenges in the diagnosis of intermittent maple syrup urine disease.
    Pode-Shakked N; Korman SH; Pode-Shakked B; Landau Y; Kneller K; Abraham S; Shaag A; Ulanovsky I; Daas S; Saraf-Levy T; Reznik-Wolf H; Vivante A; Pras E; Almashanu S; Anikster Y
    Eur J Med Genet; 2020 Jun; 63(6):103901. PubMed ID: 32151765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Branched-Chain Amino Acids and Brain Metabolism.
    Sperringer JE; Addington A; Hutson SM
    Neurochem Res; 2017 Jun; 42(6):1697-1709. PubMed ID: 28417264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin improves behavioral parameters and oxidative stress in zebrafish submitted to a leucine-induced MSUD protocol.
    Duarte MB; Medeiros BZ; da Silva Lemos I; da Silva GL; Alano CG; Dondossola ER; Torres CA; Effting PS; Rico EP; Streck EL
    Metab Brain Dis; 2023 Aug; 38(6):2105-2114. PubMed ID: 37099078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle-directed AAV gene therapy rescues the maple syrup urine disease phenotype in a mouse model.
    Greig JA; Jennis M; Dandekar A; Chorazeczewski JK; Smith MK; Ashley SN; Yan H; Wilson JM
    Mol Genet Metab; 2021; 134(1-2):139-146. PubMed ID: 34454844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenylbutyrate therapy for maple syrup urine disease.
    Brunetti-Pierri N; Lanpher B; Erez A; Ananieva EA; Islam M; Marini JC; Sun Q; Yu C; Hegde M; Li J; Wynn RM; Chuang DT; Hutson S; Lee B
    Hum Mol Genet; 2011 Feb; 20(4):631-40. PubMed ID: 21098507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
    Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.